96,29 €
inkl. MwSt.
Sofort per Download lieferbar
  • Format: PDF

This book describes in detail the clinical presentation, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders. The exceptional…mehr

Produktbeschreibung
This book describes in detail the clinical presentation, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders. The exceptional attention to rarer conditions is of particular importance given the considerable risk of overlooking them during diagnosis, with potential consequences for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees.

Autorenporträt
Akbar Dorgalaleh, hematologist and scientific researcher in the field of congenital bleeding disorders in the Department of Hematology and Blood Transfusion, Iran University of Medical Sciences (IUMS). Dr. Dorgalaleh’s primary interest is the diagnosis and management of congenital bleeding disorders, and he has a special interest in congenital factor XIII deficiency. He acts as a reviewer for several international journals in the field of Hematology and to date has authored about 100 papers that cover all the congenital bleeding disorders, including hemophilia, rare bleeding disorders, and inherited platelet function disorders. He has reported the clinical, laboratory, and molecular characteristics of a very large number of patients with congenital bleeding disorders.